×
Site Menu
Everything
Politics
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Health
Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
13 hours ago
3
The woody adds navtemadlin—a cause campaigner for a uncommon humor crab successful late-stage objective trials—to Ipsen’s oncology pipeline.
Read Entire Article
Homepage
Technology
Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
Related
Opinion | Where Are the Trustworthy Checkers AI Needs?
1 day ago
2
Is an AI Jobs Apocalypse Coming? Three Economists Square Off...
1 day ago
2
NASA races to save Swift telescope from falling back to Eart...
1 day ago
1
Popular
All the world's a robot-staging ground for tech entrepreneur...
5 days ago
18
Ronaldo shines as Portugal deliver 5-0 thrashing of Uzbekist...
5 days ago
18
Agility, Maker of Humanlike Robots, to Go Public in $2.5 Bil...
5 days ago
14
SoftBank’s Son Sets Bold Net Asset Value Target on Promise o...
5 days ago
14
Asian stocks are mixed after big tech sell-off
5 days ago
14